NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 36 filers reported holding NRX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,702 | -46.2% | 114,240 | 0.0% | 0.00% | – |
| Q2 2023 | $55,235 | -26.6% | 114,240 | 0.0% | 0.00% | – |
| Q1 2023 | $75,296 | -70.3% | 114,240 | -50.0% | 0.00% | – |
| Q4 2022 | $253,612 | +198.4% | 228,480 | +100.0% | 0.00% | – |
| Q3 2022 | $85,000 | +23.2% | 114,240 | 0.0% | 0.00% | – |
| Q2 2022 | $69,000 | -75.4% | 114,240 | 0.0% | 0.00% | – |
| Q1 2022 | $280,000 | +471.4% | 114,240 | +1009.1% | 0.00% | – |
| Q4 2021 | $49,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 325,000 | $84,500 | 0.06% |
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $16,455 | 0.00% |
| XTX Topco Ltd | 11,809 | $3,070 | 0.00% |
| United Asset Strategies, Inc. | 18,300 | $4,758 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 160,700 | $41,782 | 0.00% |
| UBS Group AG | 1,210 | $315 | 0.00% |
| NewEdge Advisors, LLC | 7,125 | $1,853 | 0.00% |
| Lido Advisors, LLC | 13,000 | $3,380 | 0.00% |
| OSAIC HOLDINGS, INC. | 11,125 | $2,891 | 0.00% |
| WELLS FARGO & COMPANY/MN | 5,379 | $1,399 | 0.00% |